Methylphenidate ER
DLA is planning a national requirements contract for Methylphenidate ER 18 mg, 27 mg, 36 mg, and 54 mg tablets in 100-count bottles. The acquisition is unrestricted and fully competitive, using a firm-fixed-price requirements contract with a one-year base and four one-year options. It will establish a national supply source under FAR 52.216-21 for Department of War, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through DLA and VA prime vendor programs, with annual usage estimates in the Schedule of Supplies. The commercial item will be solicited under FAR Part 12 and posted on DIBBS and SAM.gov. The projected solicitation date is September 2026, though DLA may issue it before or after that date.